We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

86 hedge funds and large institutions have $153M invested in BioDelivery Sciences International, Inc. in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

268% more call options, than puts

Call options by funds: $420K | Put options by funds: $114K

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

37% more capital invested

Capital invested by funds: $112M → $153M (+$41.3M)

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

4% more funds holding

Funds holding: 8386 (+3)

4% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 24

Holders
86
Holders Change
+3
Holders Change %
+3.61%
% of All Funds
1.92%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
21
Increased
23
Reduced
24
Closed
18
Calls
$420K
Puts
$114K
Net Calls
+$306K
Net Calls Change
+$43K
Name Holding Trade Value Shares
Change
Change in
Stake
EIM
26
Essex Investment Management
Massachusetts
$1.32M -$76.1K -21,659 -6%
Barclays
27
Barclays
United Kingdom
$1.21M +$1.04M +296,582 +943%
CCM
28
Cadence Capital Management
Massachusetts
$1.18M +$1.12M +319,347 New
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$990K +$877K +249,728 +1,397%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$960K
LCM
31
Laurion Capital Management
New York
$928K +$882K +251,009 New
FI
32
Fosun International
China
$834K -$930K -264,893 -48%
PCM
33
Penn Capital Management
Pennsylvania
$833K +$791K +225,201 New
WVP
34
Worth Venture Partners
New Jersey
$754K +$472K +134,256 +192%
GPGA
35
Grandeur Peak Global Advisors
Utah
$708K -$21.2K -6,050 -3%
Northern Trust
36
Northern Trust
Illinois
$701K -$6.2K -1,765 -0.9%
SC
37
Searle & Co
Connecticut
$676K -$5.27K -1,500 -0.8%
EA
38
Emerald Advisers
Pennsylvania
$654K +$621K +176,730 New
EMFAT
39
Emerald Mutual Fund Advisers Trust
Pennsylvania
$615K +$584K +166,265 New
KF
40
Krilogy Financial
Missouri
$577K
NFG
41
Next Financial Group
Texas
$398K +$136K +38,600 +56%
Two Sigma Investments
42
Two Sigma Investments
New York
$371K +$219K +62,443 +166%
Dimensional Fund Advisors
43
Dimensional Fund Advisors
Texas
$337K
BFM
44
Boothbay Fund Management
New York
$322K +$305K +86,896 New
State Street
45
State Street
Massachusetts
$308K -$4.92K -1,400 -2%
Wells Fargo
46
Wells Fargo
California
$266K -$163K -46,365 -39%
EGM
47
Engineers Gate Manager
New York
$245K +$233K +66,340 New
ECM
48
ExodusPoint Capital Management
New York
$238K +$226K +64,307 New
Parallax Volatility Advisers
49
Parallax Volatility Advisers
California
$200K +$190K +54,170 New
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
$192K +$7.02K +2,000 +4%

BDSI Hedge Fund Activity: Q4 2018 in Review

86 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2018, worth a combined $153M — up 37% from $112M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new BDSI positions and 18 closed out — a net gain of 3 holders — while 23 added to existing stakes and 24 trimmed.

The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $7.01M. The largest seller was Armistice Capital, exiting entirely with an estimated $9.22M sold.

  • 86 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2018, up from 83 in Q3 2018.
  • Funds reported $153M of BioDelivery Sciences International, Inc. stock for Q4 2018, up 37% quarter-over-quarter.
  • 21 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2018 and 18 closed out, a net change of +3 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q4 2018 was Rubric Capital Management (New York), an estimated $7.01M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q4 2018 was Armistice Capital, an estimated $9.22M sold.

Based on aggregated 13F filings for Q4 2018.